Annual report [Section 13 and 15(d), not S-K Item 405]

MEZZANINE EQUITY (Details)

v3.25.0.1
MEZZANINE EQUITY (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Mar. 31, 2021
USD ($)
observer
$ / shares
shares
Dec. 31, 2024
USD ($)
owner
$ / shares
shares
Dec. 31, 2023
shares
May 02, 2024
$ / shares
shares
Mar. 31, 2022
shares
Temporary Equity [Line Items]          
Number of institutional shareholders | owner   3      
Convertible preferred stock issued by each unit (in shares) 1        
Warrants issued (in shares)   38,089,476   1,000,000  
Warrants exercise price (in dollars per share) | $ / shares   $ 0.73   $ 0.32  
Shares outstanding after conversions, percentage     50.00%    
Shares of stock for each warrant (in shares)         2.5
Warrant          
Temporary Equity [Line Items]          
Warrants term 4 years        
Mixed Unit with Convertible Preferred Stock and Warrant          
Temporary Equity [Line Items]          
Value of units purchased | $ $ 23,000        
Price per unit (in dollars per share) | $ / shares $ 3.70        
Shares issued at closing (in shares) 6,216,216        
Hadron Healthcare Master Fund | Warrant          
Temporary Equity [Line Items]          
Warrants exercise price (in dollars per share) | $ / shares $ 1.087        
Hadron Healthcare Master Fund | Common stock | Maximum          
Temporary Equity [Line Items]          
Warrants issued (in shares) 15,540,540        
Series B Convertible Preferred Stock          
Temporary Equity [Line Items]          
Conversion of common stock to preferred stock (in shares)   4,908,333      
Exercise price pre share (in dollars per share) | $ / shares   $ 3.00      
Term of option to convert   6 years      
Conversion price (in dollars per share) | $ / shares   $ 3.00      
VWAP prior to six-year anniversary (in dollars per share) | $ / shares   $ 4.00      
Number of consecutive trading days   20 days      
Number of consecutive trading days after six year anniversary   60 days      
VWAP, less than or equal to (in dollars per share) | $ / shares   $ 0.50      
Conversion ratio   1      
Value of shares converted | $   $ 14,725      
VWAP, greater than (in dollars per share) | $ / shares   $ 0.50      
Series B Convertible Preferred Stock | Two Unaffiliated Institutional Shareholders | Exchange Agreement          
Temporary Equity [Line Items]          
Conversion of common stock to preferred stock (in shares)   4,908,333 4,908,333    
Series C Convertible Preferred Stock          
Temporary Equity [Line Items]          
Conversion of common stock to preferred stock (in shares)     5,060,942    
Series C Convertible Preferred Stock | Minimum          
Temporary Equity [Line Items]          
Outstanding percentage. 50.00%        
Series C Convertible Preferred Stock | Hadron Healthcare Master Fund          
Temporary Equity [Line Items]          
Additional amount eligible for draw down | $ $ 46,000        
Number of observers to board | observer 1        
Common stock          
Temporary Equity [Line Items]          
Conversion of common stock to preferred stock (in shares)     25,304,710    
Number of shares issued upon conversion (in shares) 5   5